Comparison of Robust Criteria for D-Optimal Designs

By Foo Lee Kien  

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1193-1205

Taylor & Francis Ltd

Access to resources Recommend Favorite

Methods of Robust Design of Nonlinear Models with an Application to Pharmacokinetics

By Foo Lee-Kien   Duffull Stephen  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 4, 2010-07 ,pp. : 886-902

Taylor & Francis Ltd

Access to resources Recommend Favorite

Comparison of the Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg and Cyclobenzaprine Immediate-Release 10 mg Three Times Daily in the Elderly: A Randomized, Open-Label, Crossover Study

By Darwish Mona  

Drugs & Aging, Vol. 26, Iss. 2, 2009-01 ,pp. : 95-101

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Measures, Their Estimation and Selection of Sampling Times

By Fedorov Valerii   Leonov Sergei  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 5, 2007-09 ,pp. : 919-941

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

By Bockbrader Howard N.   Wesche David   Miller Raymond   Chapel Sunny   Janiczek Nancy   Burger Paula  

Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. : 661-669

Adis International

Access to resources Recommend Favorite